Vericel Corporation (VCEL) P/E Ratio History
Deep ValueTrading at 126.5x · 18th percentile of 5-year range · Significant discount to historical valuation · Data 2020–2026
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Vericel Corporation (VCEL) trades at a price-to-earnings ratio of 126.5x, with a stock price of $40.47 and trailing twelve-month earnings per share of $0.42.
The current P/E is 88% below its 5-year average of 1023.1x. Over the past five years, VCEL's P/E has ranged from a low of 77.2x to a high of 6747.1x, placing the current valuation at the 18th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, VCEL trades at a 472% premium to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.
The PEG ratio of 3.17 (P/E divided by 60% EPS growth) suggests the stock may be expensive relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, VCEL commands a significant premium over the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our VCEL DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
VCEL Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
VCEL P/E vs Peers
Regenerative Medicine and Tissue Engineering peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $545M | 11.5Lowest | -Best | +14%Best |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
VCEL Historical P/E Data (2020–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $32.17 | $0.42 | 77.2x | -92% |
| FY2025 Q4 | Dec 31 2025 | $36.01 | $0.31 | 117.4x | -89% |
| FY2025 Q3 | - | $31.47 | $0.24 | 132.9x | -87% |
| FY2025 Q2 | Jun 30 2025 | $42.55 | $0.12 | 352.8x | -66% |
| FY2025 Q1 | Mar 31 2025 | $44.62 | $0.04 | 1260.5x | +23% |
| FY2024 Q4 | - | $54.91 | $0.19 | 296.5x | -71% |
| FY2024 Q3 | Sep 30 2024 | $42.25 | $0.07 | 648.0x | -37% |
| FY2024 Q2 | Jun 30 2024 | $45.88 | $0.01 | 6747.1x | +559% |
| FY2021 Q2 | Jun 30 2021 | $52.50 | $0.18 | 296.8x | -71% |
| FY2021 Q1 | Mar 31 2021 | $55.55 | $0.08 | 707.6x | -31% |
| FY2020 Q4 | - | $30.88 | $0.05 | 617.6x | -40% |
Average P/E for displayed period: 1023.1x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
VCEL — Frequently Asked Questions
Quick answers to the most common questions about buying VCEL stock.
What is VCEL's P/E ratio?
Vericel Corporation (VCEL) trailing twelve-month P/E ratio is 126.5x, based on TTM diluted EPS of $0.42. The 5-year average P/E is 1023.1x and the historical range spans 77.2x to 6747.1x.
Is VCEL stock overvalued or undervalued?
VCEL trades at 126.5x P/E, below its 5-year average of 1023.1x. At the 18th percentile of its historical range (77.2x–6747.1x), the stock is priced at a discount to its own history.
Is VCEL stock expensive?
No, VCEL is not expensive on a historical basis. The current P/E of 126.5x is below the 5-year average of 1023.1x and sits at the 18th percentile of its valuation range.
What is VCEL's historical P/E range?
Over the past 5 years, VCEL's P/E ratio has ranged from 77.2x to 6747.1x, with a median of 352.8x and an average of 1023.1x. The current P/E of 126.5x places the stock at the 18th percentile of this range. Full historical data spans 2020–2026.
How does VCEL's P/E compare to the S&P 500?
VCEL trades at 126.5x P/E versus the S&P 500 median of 24.3x. The 421% premium to the market typically reflects higher expected earnings growth or quality.
How does VCEL's valuation compare to Healthcare peers?
Vericel Corporation P/E of 126.5x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is VCEL's PEG ratio?
VCEL PEG ratio is 3.17, based on a P/E of 126.5x and EPS growth of 60.0%. A PEG above 2.0 indicates a premium valuation relative to earnings growth — typically considered expensive.
What is VCEL's earnings yield?
VCEL earnings yield is 0.79%, the inverse of its 126.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.